AlphaFold predicted structure
EPAS1 · Q99814

Mean pLDDT
58.6/ 100
Low
870 residues
Confidence breakdown
- Very high(≥ 90)29%
- Confident(70–90)6%
- Low(50–70)12%
- Very low(< 50)53%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
endothelial PAS domain protein 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Hereditary Erythrocytosis
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownInherited phaeochromocytoma and paraganglioma excluding NF1
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownerythrocytosis, familial, 4
renal cell carcinoma
clear cell renal carcinoma
autosomal dominant secondary polycythemia
von Hippel-Lindau disease
paraganglioma
neoplasm
hemangioblastoma
atrial fibrillation
pancreatic neuroendocrine tumor
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Endothelial PAS domain-containing protein 1
Transcription factor involved in the induction of oxygen regulated genes. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation requires recruitment of transcriptional coactivators such as CREBBP and probably EP300. Interaction with redox regulatory protein APEX1 seems to activate CTAD (By similarity)
Curated MONDO disease pages that list EPAS1 among their top associated genes.
EPAS1 · Q99814

Mean pLDDT
58.6/ 100
Low
870 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0